Western immunoblotting was performed to analyze the expression of ECM1 in HCT15 cells after 24 h of treatment with a variety of 5-FU doses first to understand the functional relationship between ECM1 and the chemoresistance of CRC cells to 5-FU. The gene discussed is ECM1; the disease is colorectal carcinoma.